Big Law

Financiers complete $250m raise for Challenger

Ashurst has advised on Challenger’s $250 million capital raising.

October 16, 2020 • By Tony Zhang

Firms: Ashurst (consortium).

This content is available exclusively to Lawyers Weekly premium members.

INDIVIDUAL

Yearly

$ 49.00

per year

SUBSCRIBE NOW

INDIVIDUAL

Monthly

$ 5.00

per month

SUBSCRIBE NOW

Learn more about Premium Benefits and other offers

Username or Email

Password Forgot password?

Keep me signed in on this device.

Deal: Global law firm Ashurst has advised National Australia Bank, UBS and Westpac Institutional Bank as arrangers and joint lead managers of an offer of non-cumulative, convertible, transferable, redeemable, subordinated, perpetual unsecured notes by Challenger Limited to raise $250 million.

Value: $250 million.

Area: Capital markets.

Key players: The Ashurst team was led by partner Sarah Dulhunty, assisted by senior associate Simon Vose and lawyer Kyle McLachlan.

VIEW ALL

Deal significance: The offer includes an institutional offer, a broker firm offer, a reinvestment offer and a securityholder offer.

Under the reinvestment offer, eligible holders of Challenger Capital Notes 1 (CCN1) are able to reinvest in Challenger Capital Notes 3.

In addition to the offer and reinvestment offer, eligible CCN1 holders may choose to have their CCN1 repurchased for their face value of $100 each, payable in cash.

Challenger intends to use the proceeds of the offer to fund the regulatory capital requirements of Challenger Life Company Limited, the registered life company of the Challenger Group, and to refinance the Challenger Capital Notes 1 (issued in 2014) through the reinvestment offer and repurchase invitation.